Associated Papers
The Impact of Spliceosome Inhibition in SF3B1-Mutated Uveal Melanoma.
Nguyen JQN et al.
Investigative Ophthalmology & Visual Science, 2024
Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC.
Sakthikumar S et al.
Veterinary and Comparative Oncology, 2023
37248814 (PubMed )
Supplement: supplement_1.xlsx › Supp._Table_5
Investigating the Role of DUSP4 in Uveal Melanoma.
Aughton K et al.
Translational Vision Science & Technology, 2022
36576731 (PubMed )
Supplement: tvst-11-12-13_s004.pdf
Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence.
Yu L et al.
Molecular Oncology, 2022
Analytical Validation and Performance of a 7-Gene Next-Generation Sequencing Panel in Uveal Melanoma.
Alsina KM et al.
Ocular Oncology and Pathology, 2021
The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach.
Rezzola S et al.
Cancers, 2019
Somatic genetic alterations in synchronous and metachronous low-grade serous tumours and high-grade carcinomas of the adnexa.
Murali R et al.
Histopathology, 2019
eIF1A residues implicated in cancer stabilize translation preinitiation complexes and favor suboptimal initiation sites in yeast.
Martin-Marcos P et al.
Elife, 2017
Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
Scholz SL et al.
Investigative Ophthalmology & Visual Science, 2017
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma.
Moore AR et al.
Nature Genetics, 2016
Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.
Amirouchene-Angelozzi N et al.
Molecular Oncology, 2014
Select a paper to view details